Activation of SIGMAR1 is expected to restore cellular homeostasis by inducing autophagy, which may slow neurodegeneration in patients with early AD.

Screening to prevent osteoporotic fractures also recommended for postmenopausal women younger than 65 years at increased risk; evidence lacking for screening men ...

HealthDay News — Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, according to a study ...

HealthDay News — Three main themes may largely explain COVID-19 vaccine hesitancy among Black women in the US: mistrust in health care and government, concerns over vaccine safety, and disapproval of ...

Kevin H. Yang, MD, from the University of California, San Diego, and colleagues used data from the 2015 to 2022 National Survey on Drug Use and Health to examine trends in past-year ketamine use by ...

Clinical obesity defined as chronic illness resulting from effect of excess adiposity on organ and tissue function.

Linsitinib is an oral small molecule that inhibits the activity of insulin-like growth factor-1 receptor (IGF-1R). It is believed that inhibition of IGF-1R may help reduce orbital inflammation and ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...

Reduction seen in risk for readmission, wound dehiscence, and hematoma, but no significant differences seen in rates of infection, bleeding ...

Reductions seen in median Gastrointestinal Symptom Rating Scale-Irritable Bowel Syndrome score, Patient Assessment of Gastrointestinal Symptom Severity Index ...

Four-month regimen recommended for drug-susceptible TB and six-month regimen recommended for drug-resistant TB ...